PMV Pharmaceuticals Inc (NASDAQ:PMVP) shares, rose in value on Thursday, April 16, with the stock price up by 2.00% to the previous day’s close as strong demand from buyers drove the stock to $1.02.
Actively observing the price movement in the last trading, the stock closed the session at $1.00, falling within a range of $0.952 and $1.04. The value of beta (5-year monthly) was 1.489. Referring to stock’s 52-week performance, its high was $2.26, and the low was $0.82. On the whole, PMVP has fluctuated by -20.31% over the past month.
With the market capitalization of PMV Pharmaceuticals Inc currently standing at about $52.97 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Mar-02.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that PMVP’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of PMVP currently trading nearly -1.89% and -16.55% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 43.94, while the 7-day volatility ratio is showing 10.82% which for the 30-day chart, stands at 10.15%. Furthermore, PMV Pharmaceuticals Inc (PMVP)’s beta value is 1.46, and its average true range (ATR) is 0.09.
A comparison of PMV Pharmaceuticals Inc (PMVP) with its peers suggests the former has fared considerably weaker in the market. PMVP showed an intraday change of 2.00% in last session, and over the past year, it shrunk by -36.25%%.
Data on historical trading for PMV Pharmaceuticals Inc (NASDAQ:PMVP) indicates that the trading volumes over the past 10 days have averaged 0.16 and over the past 3 months, they’ve averaged 126.40K. According to company’s latest data on outstanding shares, there are 51.94 million shares outstanding.
Nearly 15.68% of PMV Pharmaceuticals Inc’s shares belong to company insiders and institutional investors own 72.05% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 0.84 million shares as on 2025-03-31, resulting in a short ratio of 7.72. According to the data, the short interest in PMV Pharmaceuticals Inc (PMVP) stood at 189.00 of shares outstanding as of 2025-03-31; the number of short shares registered in 2025-02-28 reached 0.88 million. The stock has fallen by -32.45% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the PMVP stock heading into the next quarter.
